Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus

[1]  L. Borradori,et al.  The pathogenesis of pemphigus: Controversy vs complexity , 2017, Experimental dermatology.

[2]  S. Tufik,et al.  The role of sleep in pemphigus: a review of mechanisms and perspectives , 2017, Archives of Dermatological Research.

[3]  S. Tavakolpour,et al.  Rituximab administration in a patient with pemphigus vulgaris following reactivation of occult hepatitis B virus infection. , 2017, Dermatology online journal.

[4]  M. Petzl-Erler,et al.  CD59 polymorphisms are associated with gene expression and different sexual susceptibility to pemphigus foliaceus , 2017, Autoimmunity.

[5]  K. Zeng,et al.  Increased miR-424-5p expression in peripheral blood mononuclear cells from patients with pemphigus , 2017, Molecular medicine reports.

[6]  D. Popadic,et al.  Pemphigus vulgaris and pemphigus foliaceus determined by CD86 and CTLA4 polymorphisms. , 2017, Clinics in dermatology.

[7]  S. Tavakolpour,et al.  Management of pemphigus disease in pregnancy , 2017, American journal of reproductive immunology.

[8]  S. Tavakolpour,et al.  Skin Cancer: Genetics, Immunology, Treatments, and Psychological Care , 2017 .

[9]  S. Tavakolpour,et al.  The possible role of interleukin-35 and its therapeutic potential in pemphigus. , 2017, International immunopharmacology.

[10]  S. Tavakolpour,et al.  New Insights into the Management of Patients with Autoimmune Diseases or Inflammatory Disorders During Pregnancy , 2016, Scandinavian journal of immunology.

[11]  M. Alaibac,et al.  Relapse of pemphigus vulgaris after topical application of ingenol mebutate , 2016, Clinical and experimental dermatology.

[12]  A. Tirado-Sánchez,et al.  Pemphigus vulgaris and blood group antigens: no relationship , 2016, Clinical and experimental dermatology.

[13]  E. Donadi,et al.  Differential HLA class I and class II associations in pemphigus foliaceus and pemphigus vulgaris patients from a prevalent Southeastern Brazilian region. , 2016, Journal of autoimmunity.

[14]  Vinod K. Sharma,et al.  Clinical efficacy of rituximab in the treatment of pemphigus: A retrospective study , 2016, Indian journal of dermatology, venereology and leprology.

[15]  S. Tavakolpour,et al.  The dual nature of retinoic acid in pemphigus and its therapeutic potential: Special focus on all-trans Retinoic Acid. , 2016, International immunopharmacology.

[16]  S. Tavakolpour.  The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature , 2016, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[17]  Hong Shen,et al.  Immunohistochemical study of toll-like receptors 2, 4, and 9 expressions in pemphigus and bullous pemphigoid lesions , 2016, Archives of Dermatological Research.

[18]  S. Tavakolpour.  Interleukin 21 as a new possible player in pemphigus: Is it a suitable target? , 2016, International immunopharmacology.

[19]  O. Sarig,et al.  Identification of a Functional Risk Variant for Pemphigus Vulgaris in the ST18 Gene , 2016, PLoS genetics.

[20]  S. Alavian,et al.  Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review , 2016, Hepatitis monthly.

[21]  T. Liebman,et al.  Pemphigus foliaceus exacerbated by radiation, in association with myasthenia gravis. , 2016, Dermatology online journal.

[22]  C. Chams‐Davatchi,et al.  Trauma‐induced pemphigus: a case series of 36 patients , 2016, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[23]  R. Mandal,et al.  Tumor necrosis factor (TNF)-α −308G/A (rs1800629) polymorphism distribution in North India and its association with pemphigus: Case–control study and meta-analysis , 2016, Autoimmunity.

[24]  S. Tavakolpour,et al.  Interleukin 4 inhibition as a potential therapeutic in pemphigus. , 2016, Cytokine.

[25]  S. Hadj-Rabia,et al.  Pemphigus and depression comorbidity: a case control study , 2015, European Journal of Dermatology.

[26]  Vinod K. Sharma,et al.  Distinctive Treg associated CCR4-CCL22 expression profile with altered frequency of Th17/Treg cell in the immunopathogenesis of Pemphigus Vulgaris. , 2015, Immunobiology.

[27]  Yunjie Zeng,et al.  Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma: report of a case and review of literature. , 2015, International journal of clinical and experimental pathology.

[28]  R. Feldman.  Paradoxical worsening of pemphigus vulgaris following rituximab therapy , 2015, The British journal of dermatology.

[29]  V. Chong,et al.  Gastric Cancer and Paraneoplastic Pemphigus , 2015, Indian Journal of Surgery.

[30]  R. Wong,et al.  Mediastinal follicular dendritic cell sarcoma with paraneoplastic pemphigus , 2015, Asian cardiovascular & thoracic annals.

[31]  T. Ahmed,et al.  HLA- DR Alleles in Pakistani Patients of Pemphigus Vulgaris. , 2015, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[32]  D. Zillikens,et al.  Pemphigus. S2 Guideline for diagnosis and treatment – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV) , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[33]  X. Liu,et al.  T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance , 2015, Cell Death and Disease.

[34]  R. Wolf,et al.  Viruses and Pemphigus: An Intriguing Never-Ending Story , 2014, Dermatology.

[35]  M. Djalali,et al.  Evaluation of Vitamin D Status in Newly Diagnosed Pemphigus Vulgaris Patients , 2014, Iranian journal of public health.

[36]  T. Hashimoto,et al.  Radiotherapy‐induced pemphigus vulgaris , 2014, The Journal of dermatology.

[37]  P. Cetkovska,et al.  Management of a pemphigus with IgA and IgG antibodies and coexistent lung cancer , 2014, Dermatologic therapy.

[38]  O. Shaker,et al.  Estimation of vitamin D levels in patients with pemphigus vulgaris , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[39]  Y. Kong,et al.  Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1 , 2014, Front. Immunol..

[40]  E. Ruocco,et al.  Pemphigus induced by radiotherapy for breast cancer: an instance of immunocompromised district , 2014, European Journal of Dermatology.

[41]  L. Machet,et al.  Pemphigus induced by radiotherapy for breast cancer: clinical, immunological and histological features of one case with antidesmoglein immunostaining , 2014, European Journal of Dermatology.

[42]  K. Amber,et al.  Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris , 2013, Experimental dermatology.

[43]  H. Turki,et al.  Cytokine gene polymorphisms in Tunisian endemic pemphigus foliaceus: a possible role of il-4 variants. , 2013, Human immunology.

[44]  H. Koga,et al.  Concurrence of bullous pemphigoid and herpetiform pemphigus with IgG antibodies to desmogleins 1/3 and desmocollins 1–3 , 2013, The British journal of dermatology.

[45]  M. C. Salmito,et al.  Paraneoplastic pemphigus: initial manifestation of lung cancer , 2013, Brazilian journal of otorhinolaryngology.

[46]  Y. Shoenfeld,et al.  Vitamin D in Systemic and Organ-Specific Autoimmune Diseases , 2013, Clinical Reviews in Allergy & Immunology.

[47]  A. Ahmed,et al.  Rituximab in the Treatment of Pemphigus Vulgaris , 2012, Dermatology and Therapy.

[48]  K. Zeng,et al.  Association between HLA-DRB1 polymorphisms and pemphigus vulgaris: a meta-analysis , 2012, The British journal of dermatology.

[49]  S. Rosset,et al.  Population-specific association between a polymorphic variant in ST18, encoding a pro-apoptotic molecule, and pemphigus vulgaris. , 2012, The Journal of investigative dermatology.

[50]  A. Sinha,et al.  Cytokine networks in Pemphigus vulgaris: An integrated viewpoint , 2012, Autoimmunity.

[51]  M. Chamari,et al.  Serum Selenium, Zinc, and Copper in Early Diagnosed Patients with Pemphigus Vulgaris , 2012, Iranian journal of public health.

[52]  H. Fathy,et al.  Tumor necrosis factor-α -308 G>A and interleukin-6 -174 G>C promoter polymorphisms and pemphigus. , 2012, Human immunology.

[53]  N. Gholizadeh,et al.  Pemphigus Vulgaris Associated with Rheumatoid Arthritis in a Patient not Taking Penicillamine , 2012, Journal of dental research, dental clinics, dental prospects.

[54]  Jiansheng Zhou,et al.  Estrogen Stimulates Th2 Cytokine Production and Regulates the Compartmentalisation of Eosinophils during Allergen Challenge in a Mouse Model of Asthma , 2012, International Archives of Allergy and Immunology.

[55]  T. Badri,et al.  Radiotherapy‐induced pemphigus vulgaris with autoantibodies targeting a 110 kDa epidermal antigen , 2011, International journal of dermatology.

[56]  J. Chung,et al.  Pemphigus Foliaceus Associated with Psoriasis during the Course of Narrow-Band UVB Therapy: A Simple Coincidence? , 2011, Annals of dermatology.

[57]  M. Yazdanpanah,et al.  Serum zinc and copper status in Iranian patients with pemphigus vulgaris , 2011, International journal of dermatology.

[58]  R. Robati,et al.  Pemphigus vulgaris and season: are they really related or not? , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[59]  C. Chams‐Davatchi,et al.  Pemphigus and pregnancy: a 23-year experience. , 2011, Indian journal of dermatology, venereology and leprology.

[60]  A. Sinha.  The genetics of pemphigus. , 2011, Dermatologic clinics.

[61]  Hu Wei-xing.  Intravenous immunoglobulin therapy and systemic lupus erythematosus , 2011 .

[62]  C. Magro,et al.  Combined bullous pemphigoid and pemphigus vulgaris in an 18‐year‐old female , 2010, Journal of cutaneous pathology.

[63]  H. Grosse-wilde,et al.  TNF‐α and IL‐10 gene polymorphisms show a weak association with pemphigus vulgaris in the Slovak population , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[64]  M. Fallahzadeh,et al.  ABO blood groups and pemphigus vulgaris: no relationship. , 2010, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.

[65]  T. Torres,et al.  Pemphigus vegetans in a patient with colonic cancer. , 2009, Indian journal of dermatology, venereology and leprology.

[66]  M. Worm,et al.  Advances in the management of UVR‐associated skin cancers: autoimmune diseases and UV protection , 2009, The British journal of dermatology.

[67]  M. Mokni,et al.  Tunisian endemic pemphigus foliaceus is associated with the HLA‐DR3 gene: anti‐desmoglein 1 antibody‐positive healthy subjects bear protective alleles , 2009, The British journal of dermatology.

[68]  E. Ruocco,et al.  Pemphigus and drug addiction , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[69]  G. Vena,et al.  Pemphigus vulgaris with circulating anti-desmoglein 3 and anti-BP180 antibodies: a case report and brief review of cases with coexistence of pemphigus vulgaris and bullous pemphigoid. , 2009, Journal of biological regulators and homeostatic agents.

[70]  A. Bauzá,et al.  Pemphigus‐like lesions induced by imiquimod , 2009, Clinical and experimental dermatology.

[71]  H. Mouquet,et al.  ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus. , 2009, Archives of dermatology.

[72]  P. Amerio,et al.  Exacerbation of pemphigus after influenza vaccination , 2008, Clinical and experimental dermatology.

[73]  C Colosio,et al.  Effects of pesticide exposure on the human immune system , 2008, Human & experimental toxicology.

[74]  E. Ruocco,et al.  Contact pemphigus: a side‐effect of imiquimod therapy , 2008, International journal of dermatology.

[75]  C. Chams‐Davatchi,et al.  Impact of smoking on pemphigus , 2008, International journal of dermatology.

[76]  L. Trautmann,et al.  T-cell exhaustion in HIV infection , 2008, Current HIV/AIDS reports.

[77]  E. Hachulla,et al.  Stressful Life Events and Pemphigus , 2008, Dermatology.

[78]  L. Stojanovich,et al.  Stress as a trigger of autoimmune disease. , 2008, Autoimmunity reviews.

[79]  M. Simmonds,et al.  The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action , 2007, Current genomics.

[80]  G. Kavand,et al.  ABO blood groups, rhesus factor and pemphigus , 2007 .

[81]  N. Allı,et al.  Pemphigus vulgaris following antirabies vaccination , 2007, The Journal of dermatology.

[82]  Y. Marfatia,et al.  Human immunodeficiency virus and pemphigus vulgaris: an interesting association. , 2007, Indian journal of dermatology, venereology and leprology.

[83]  Manfred S. Green,et al.  Pemphigus variant associated with penicillin use: a case-cohort study of 363 patients from Israel. , 2007, Archives of dermatology.

[84]  C. Chams‐Davatchi,et al.  Pemphigus and associated environmental factors: a case–control study , 2007, Clinical and experimental dermatology.

[85]  A. Ahmed,et al.  Concurrence of Systemic Lupus Erythematosus and Pemphigus: Coincidence or Correlation? , 2007, Dermatology.

[86]  R. Watanabe,et al.  Pemphigus foliaceus induced by bucillamine. , 2007, European journal of dermatology : EJD.

[87]  Razieh Soltani-Arabshahi,et al.  Chloroquine/hydroxychloroquine‐induced pemphigus , 2006, International journal of dermatology.

[88]  M. Petzl-Erler,et al.  Polymorphism of the promoter region and exon 1 of the CTLA4 gene in endemic pemphigus foliaceus (fogo selvagem). , 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[89]  E. Stratman,et al.  Ionizing radiation-induced pemphigus foliaceus. , 2006, Journal of the American Academy of Dermatology.

[90]  A. Scope,et al.  The role of IVIg treatment in severe pemphigus vulgaris , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[91]  M. McDermott,et al.  Pemphigus vulgaris induced by electrical injury. , 2006, Cutis.

[92]  S. Brenner,et al.  A burning issue: burns and other triggers in pemphigus. , 2006, Cutis.

[93]  M. Namazi,et al.  Epidemiology of pemphigus in south‐western Iran: A 10‐year retrospective study (1991–2000) , 2006, International journal of dermatology.

[94]  B. Sarah,et al.  Chlorpyrifos exacerbating pemphigus vulgaris: a preliminary report and suggested in vitro immunologic evaluation model. , 2006 .

[95]  T. Nishikawa,et al.  Tolerance induction by the blockade of CD40/CD154 interaction in pemphigus vulgaris mouse model. , 2006, The Journal of investigative dermatology.

[96]  S. Brenner,et al.  Chlorpyrifos exacerbating pemphigus vulgaris: a preliminary report and suggested in vitro immunologic evaluation model. , 2006, Skinmed.

[97]  M. Gönül,et al.  Pemphigus vulgaris induced by honeybee sting? , 2006, Acta dermato-venereologica.

[98]  A. Srebrnik,et al.  Pemphigus vulgaris triggered by glibenclamide and cilazapril. , 2005, Acta dermatovenerologica Croatica : ADC.

[99]  Y. Shoenfeld,et al.  Pemphigus following hepatitis B vaccination-coincidence or causality? , 2005, Autoimmunity.

[100]  Hiroyuki Suzuki,et al.  Co-existence of pemphigus vulgaris and Hashimoto's thyroiditis. , 2005, European journal of dermatology : EJD.

[101]  M. Petzl-Erler,et al.  Cytokine gene polymorphisms in endemic pemphigus foliaceus: a possible role for IL6 variants. , 2004, Cytokine.

[102]  E. Giansante,et al.  Systemic lupus erythematosus and pemphigus vulgaris: association or coincidence , 2004, Lupus.

[103]  B. Sarah,et al.  Pemphigus vulgaris triggered by rifampin and emotional stress. , 2004 .

[104]  D. Ladd,et al.  Localized pemphigus foliaceus induced by topical imiquimod treatment. , 2004, Archives of dermatology.

[105]  H. Matz,et al.  Pemphigus vulgaris induced by radiotherapy , 2004, Journal of the European Academy of Dermatology and Venereology : JEADV.

[106]  M. Davies,et al.  Pemphigus foliaceus: an adverse reaction to lisinopril , 2004, The Journal of dermatological treatment.

[107]  S. Brenner,et al.  Pemphigus vulgaris triggered by rifampin and emotional stress. , 2004, Skinmed.

[108]  C. Vullo,et al.  Cytokine polymorphisms in patients with pemphigus , 2004, Archives of Dermatological Research.

[109]  K. Harman,et al.  Guidelines for the management of pemphigus vulgaris , 2003, The British journal of dermatology.

[110]  M. Kowalski,et al.  Tumour necrosis factor-alpha polymorphism as one of the complex inherited factors in pemphigus. , 2003, Mediators of inflammation.

[111]  S. Brenner,et al.  Pemphigus in Israel--an epidemiologic analysis of cases in search of risk factors. , 2003, The Israel Medical Association journal : IMAJ.

[112]  M. Davies,et al.  Carbamazepine‐induced pemphigus , 2003, Clinical and experimental dermatology.

[113]  R. Kirsner,et al.  Pemphigus and smoking , 2002, International journal of dermatology.

[114]  A. Parodi,et al.  Fosinopril as a Possible Pemphigus-Inducing Drug , 2002, Dermatology.

[115]  J. Uitto,et al.  Exacerbation of pemphigus foliaceus after tetanus vaccination accompanied by synthesis of auto-antibodies against paraneoplastic pemphigus antigens. , 2002, Acta dermato-venereologica.

[116]  V. Ruocco,et al.  Pemphigus vulgaris: environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire , 2001, International journal of dermatology.

[117]  R. Marinho,et al.  Oropharyngeal pemphigus in a patient with chronic hepatitis C during interferon alpha-2a therapy. , 2001, European journal of gastroenterology & hepatology.

[118]  V. Ruocco,et al.  Pemphigus and diet: does a link exist? , 2001, International journal of dermatology.

[119]  E. Orion,et al.  Pemphigus vulgaris Induced by Diazinon and Sun Exposure , 2000, Dermatology.

[120]  S. Grando,et al.  Nicotine and pemphigus. , 2000, Archives of dermatology.

[121]  L. Lo Muzio,et al.  Pemphigus induction by influenza vaccination , 2000, International journal of dermatology.

[122]  J. Roujeau,et al.  HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus. , 2000, Journal of autoimmunity.

[123]  E. Orion,et al.  Pemphigus vulgaris possibly triggered by Cilazapril. , 2000, Acta dermato-venereologica.

[124]  L. Diaz,et al.  UVB-induced acantholysis in endemic Pemphigus foliaceus (Fogo selvagem) and Pemphigus vulgaris. , 2000, Journal of the American Academy of Dermatology.

[125]  N. Tsankov,et al.  Epidemiology of pemphigus in Sofia, Bulgaria. A 16‐year retrospective study (1980–1995) , 2000, International journal of dermatology.

[126]  Ann G. Martin,et al.  A case of pemphigus vulgaris improved by cigarette smoking. , 2000, Archives of dermatology.

[127]  T. Nishikawa,et al.  Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression , 1999, The British journal of dermatology.

[128]  K. Gaido,et al.  Comparative estrogenic activity of wine extracts and organochlorine pesticide residues in food. , 1998, Environmental health perspectives.

[129]  S. R. Cohen,et al.  Pemphigus vegetans-Neumann variant associated with intranasal heroin abuse. , 1998, Journal of the American Academy of Dermatology.

[130]  M. González-Escribano,et al.  Distribution of HLA class II alleles among Spanish patients with pemphigus vulgaris. , 1998, Tissue antigens.

[131]  N. Tsankov,et al.  Contact pemphigus induced by dihydrodiphenyltrichlorethane. , 1998, European journal of dermatology : EJD.

[132]  Y. Yamashina,et al.  Polymorphisms of HLA class II genes in Japanese patients with pemphigus vulgaris. , 1998, Tissue antigens.

[133]  F. Camacho,et al.  Pemphigus foliaceus associated with cilazapril. , 1998, Acta dermato-venereologica.

[134]  V. Ruocco,et al.  Drug-induced pemphigus. , 1998, Clinics in dermatology.

[135]  C. Meshul,et al.  Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells. , 1997, Investigative ophthalmology & visual science.

[136]  S. Brenner,et al.  Dipyrone in the induction of pemphigus. , 1997, Journal of the American Academy of Dermatology.

[137]  R Boero,et al.  HLA haplotypes and class II molecular alleles in Sardinian and Italian patients with pemphigus vulgaris. , 1996, Tissue antigens.

[138]  T. Muramatsu,et al.  Pemphigus Vulgaris Exacerbated by Exposure to Sunlight , 1996, The Journal of dermatology.

[139]  A. Ahmed,et al.  Influence of treatment on the clinical course of pemphigus vulgaris. , 1996, Journal of the American Academy of Dermatology.

[140]  A. Inamadar.  Association of alopecia areata, vitiligo and pemphigus vulgaris. , 1995, Indian journal of dermatology, venereology and leprology.

[141]  A. Tosca,et al.  ENVIRONMENTAL FACTORS INFLUENCING THE BIOLOGIC BEHAVIOR OF PATTERNS OF PEMPHIGUS VULGARIS: EPIDEMIOLOGIC APPROACH , 1995, International journal of dermatology.

[142]  A. Butt,et al.  Pemphigus vulgaris induced by captopril , 1995, The British journal of dermatology.

[143]  R. Wolf,et al.  CONTACT PEMPHIGUS: A SUBGROUP OF INDUCED PEMPHIGUS , 1994, International journal of dermatology.

[144]  M. Lebwohl,et al.  Pemphigus vulgaris after initiation of psoralen and UVA therapy for psoriasis. , 1994, Journal of the American Academy of Dermatology.

[145]  S. Brenner,et al.  Pemphigus vulgaris triggered by emotional stress. , 1984, Dermatology.

[146]  T. Nishikawa,et al.  A case of pemphigus foliaceus after interferon alpha-2a therapy. , 1994, Dermatology.

[147]  R. Wolf,et al.  Drug-induced pemphigus. I. A survey. , 1993, Clinics in dermatology.

[148]  R. Pellicano,et al.  PEMPHIGUS ERYTHEMATOSUS INDUCED BY CEFTAZIDIME , 1993, International journal of dermatology.

[149]  S. C. Kim,et al.  Pemphigus foliaceus induced by nifedipine. , 1993, Acta dermato-venereologica.

[150]  A. Smith,et al.  Rheumatoid arthritis: an association with pemphigus foliaceous. , 1992, Acta dermato-venereologica.

[151]  R. Kaplan,et al.  Drug-induced pemphigus related to angiotensin-converting enzyme inhibitors. , 1992, Journal of the American Academy of Dermatology.

[152]  S. Kaveri,et al.  Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases , 1991, Clinical and experimental immunology.

[153]  D. Woodley,et al.  Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen. , 1991, Archives of dermatology.

[154]  M. Rosin.  Alopecia areata and pemphigus foliaceus. , 1985, Journal of the American Academy of Dermatology.

[155]  J. Zone,et al.  Penicillamine-induced pemphigus. , 1982, JAMA.

[156]  E. Dabelsteen,et al.  Pemphigus vulgaris and pemphigus foliaceus coexisting with oral lichen planus , 1980, The British journal of dermatology.

[157]  M. Fellner,et al.  PEMPHIGUS ERYTHEMATOSUS AND HEROIN ADDICTION , 1978, International journal of dermatology.

[158]  R. J. Cairns.  Penicillamine-Induced Pemphigus , 1976, Proceedings of the Royal Society of Medicine.

[159]  J. Buczkowska,et al.  Pemphigus erythematosus confined to the post-burn scar. , 1973, Dermatologica.

[160]  H. Perry,et al.  PEMPHIGUS FOLIACEUS. FURTHER OBSERVATIONS. , 1965 .

[161]  E. Beutner,et al.  Demonstration of Skin Antibodies in Sera of Pemphigus Vulgaris Patients by Indirect Immunofluorescent Staining.∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.